Items where authors include "Fairclough, RJ"

Article

Abbas, A, Schini, M, Ainsworth, G orcid.org/0000-0002-9952-8440 et al. (7 more authors) (2022) Effect of AZD4017, a Selective 11β-HSD1 Inhibitor, on Bone Turnover Markers in Postmenopausal Osteopenia. Journal of Clinical Endocrinology and Metabolism. ISSN 0021-972X

Ajjan, RA, Hensor, EMA, Del Galdo, F et al. (13 more authors) (2022) Oral 11β-HSD1 inhibitor AZD4017 improves wound healing and skin integrity in adults with type 2 diabetes mellitus: a pilot randomised controlled trial. European Journal of Endocrinology. ISSN 0804-4643

Hardy, RS, Botfield, H, Markey, K et al. (16 more authors) (2021) 11βHSD1 Inhibition with AZD4017 Improves Lipid Profiles and Lean Muscle Mass in Idiopathic Intracranial Hypertension. Journal of Clinical Endocrinology and Metabolism, 106 (1). pp. 174-187. ISSN 0021-972X

Markey, K, Mitchell, J, Botfield, H et al. (22 more authors) (2020) 11β-Hydroxysteroid dehydrogenase type 1 inhibition in idiopathic intracranial hypertension: a double-blind randomized controlled trial. Brain Communications, 2 (1). fcz050.